Patient characteristics
| Number of patients | 31 |
| Age (median, range) | 54 (40-66) |
| Gender | |
| Male | 21 |
| Female | 10 |
| Prior chemotherapy | |
| Number of regimens (median, range) | 1 (1-2) |
| Prior radiotherapy (local) | 8 |
| Selection device | |
| Ceprate | 24 |
| CliniMACS | 6 |
| Isolex | 1 |
| CD34 dose (×106 cells/kg) (median, range) | 2.8 (0.7-14.2) |
| Conditioning | |
| TBI/melphalan | 22 |
| Melphalan | 9 |
| Number of patients | 31 |
| Age (median, range) | 54 (40-66) |
| Gender | |
| Male | 21 |
| Female | 10 |
| Prior chemotherapy | |
| Number of regimens (median, range) | 1 (1-2) |
| Prior radiotherapy (local) | 8 |
| Selection device | |
| Ceprate | 24 |
| CliniMACS | 6 |
| Isolex | 1 |
| CD34 dose (×106 cells/kg) (median, range) | 2.8 (0.7-14.2) |
| Conditioning | |
| TBI/melphalan | 22 |
| Melphalan | 9 |